• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹参酸缓释微囊的体外制备与评价。

In vitro Preparation and Evaluation of Sustained-Release Microcapsules of Salvianolic Acid.

机构信息

Chongqing Academy of Chinese Materia Medica, Chongqing, 400065, People's Republic of China.

Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.

出版信息

Drug Des Devel Ther. 2021 Apr 21;15:1623-1631. doi: 10.2147/DDDT.S294314. eCollection 2021.

DOI:10.2147/DDDT.S294314
PMID:33907382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8071090/
Abstract

OBJECTIVE

This study aims to investigate the preparation of sustained-release microcapsules of salvianolic acid.

METHODS

The stability of salvianolic acid microcapsules was improved, and the time of action was prolonged in the present study. This was prepared using the spray-drying method, with chitosan as the carrier. In the preparation process, the prescription and process were optimized by L9 (34) using an orthogonal design, with yield and drug loading as indexes, in order to obtain optimum conditions.

RESULTS

The optimal process and prescription for the preparation of salvianolic acid microcapsules were found to be as follows: mass concentration of chitosan, 1.5%; mass ratio of salvianolic acid to chitosan, 1:3; inlet air temperature, 190°C; and peristaltic pump speed, 300 mL·h-1. The surface of the microcapsules was round, the drug loading was 25.99% ± 2.14%, the yield was 51.88% ± 2.84%, the entrapment efficiency was 86.21% ± 2.89%, and the average particle size was 105.6 ± 2.56 nm. The microcapsules in vitro had certain sustained release characteristics. The internally fitted first-order release model equation was ln(1-Q) = -0.236 t + 4.591 7, r = 0.920. In addition, the results of differential scanning calorimetry show that the properties of salvianolic acid were not changed by the microcapsules.

CONCLUSION

Sustained-release microcapsules of salvianolic acid can be successfully prepared by adopting marine polysaccharide as a carrier.

摘要

目的

本研究旨在探讨丹酚酸长效缓释微囊的制备方法。

方法

采用喷雾干燥法,以壳聚糖为载体,提高丹酚酸微囊的稳定性,延长其作用时间。在制备过程中,采用 L9(34)正交设计,以收率和载药量为指标,对处方和工艺进行优化,以获得最佳条件。

结果

确定了丹酚酸微囊的最佳制备工艺和处方条件为:壳聚糖质量浓度 1.5%;丹酚酸与壳聚糖质量比 1:3;进风温度 190℃;蠕动泵转速 300 mL·h-1。微囊表面圆整,载药量为 25.99%±2.14%,收率为 51.88%±2.84%,包封率为 86.21%±2.89%,平均粒径为 105.6±2.56nm。微囊体外具有一定的缓释特性,拟合的内装式一级释放模型方程为 ln(1-Q)=-0.236t+4.5917,r=0.920。此外,差示扫描量热法结果表明,微囊未改变丹酚酸的性质。

结论

采用海洋多糖作为载体可成功制备丹酚酸长效缓释微囊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/d2085982b863/DDDT-15-1623-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/37368bfd30c5/DDDT-15-1623-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/b820d1846f0e/DDDT-15-1623-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/6673df339016/DDDT-15-1623-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/eb4986a2aac9/DDDT-15-1623-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/d2085982b863/DDDT-15-1623-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/37368bfd30c5/DDDT-15-1623-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/b820d1846f0e/DDDT-15-1623-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/6673df339016/DDDT-15-1623-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/eb4986a2aac9/DDDT-15-1623-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbb/8071090/d2085982b863/DDDT-15-1623-g0005.jpg

相似文献

1
In vitro Preparation and Evaluation of Sustained-Release Microcapsules of Salvianolic Acid.丹参酸缓释微囊的体外制备与评价。
Drug Des Devel Ther. 2021 Apr 21;15:1623-1631. doi: 10.2147/DDDT.S294314. eCollection 2021.
2
Preparation, evaluation, and in vitro release of chitosan-alginate tanshinone self-microemulsifying sustained-release microcapsules.丹参酮壳聚糖-海藻酸钠自微乳释药系统微囊的制备、评价及体外释放
Technol Health Care. 2021;29(4):687-695. doi: 10.3233/THC-202529.
3
Preparation and sustained-release of chitosan-alginate bilayer microcapsules containing aromatic compounds with different functional groups.含不同官能团芳香化合物的壳聚糖-海藻酸钠双层微胶囊的制备及缓释。
Int J Biol Macromol. 2024 Jun;271(Pt 2):132663. doi: 10.1016/j.ijbiomac.2024.132663. Epub 2024 May 24.
4
Preparation and Characterization of Chitosan-Based Core-Shell Microcapsules Containing Clove Oil.含丁香油的壳聚糖基核壳微胶囊的制备与表征
J Nanosci Nanotechnol. 2015 Jan;15(1):600-5. doi: 10.1166/jnn.2015.8767.
5
Effect of drug-loading methods on drug load, encapsulation efficiency and release properties of alginate/poly-L-arginine/chitosan ternary complex microcapsules.载药方法对海藻酸盐/聚-L-精氨酸/壳聚糖三元复合微胶囊载药量、包封率及释放性能的影响
Macromol Biosci. 2004 Jan 21;4(1):27-30. doi: 10.1002/mabi.200300043.
6
Preparation and characterisation of chitosan microcapsules loaded with Cortex Moutan.载牡丹皮的壳聚糖微胶囊的制备及表征。
Int J Biol Macromol. 2013 Apr;55:32-8. doi: 10.1016/j.ijbiomac.2012.12.023. Epub 2013 Jan 7.
7
Sustained release of diltiazem hydrochloride from chitosan micro-capsules.盐酸地尔硫䓬从壳聚糖微胶囊中的缓释。
Curr Drug Deliv. 2009 Jul;6(3):238-48. doi: 10.2174/156720109788680840.
8
Preparation of microcapsules with the evaluation of physicochemical properties and molecular interaction.微胶囊的制备及其物理化学性质和分子相互作用的评估
Arch Pharm Res. 2014 Dec;37(12):1570-7. doi: 10.1007/s12272-013-0306-0. Epub 2013 Dec 12.
9
Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.聚(L-谷氨酸)/壳聚糖微胶囊的层层组装用于高负载和 5-氟尿嘧啶的持续释放。
Eur J Pharm Biopharm. 2011 Aug;78(3):336-45. doi: 10.1016/j.ejpb.2010.12.031. Epub 2010 Dec 30.
10
Preparation and properties of chitosan-based microspheres by spray drying.喷雾干燥法制备壳聚糖基微球及其性能
Food Sci Nutr. 2020 Feb 28;8(4):1933-1941. doi: 10.1002/fsn3.1479. eCollection 2020 Apr.

本文引用的文献

1
Rapid and efficient extraction of chitin and chitosan for scale-up production: Effect of process parameters on deacetylation degree and molecular weight.快速高效提取甲壳素和壳聚糖以实现规模化生产:工艺参数对脱乙酰度和分子量的影响。
Int J Biol Macromol. 2019 Oct 15;139:1092-1102. doi: 10.1016/j.ijbiomac.2019.08.079. Epub 2019 Aug 9.
2
Fabrication of chitosan-based MCS/ZnO@Alg gel microspheres for efficient adsorption of As(V).壳聚糖基 MCS/ZnO@Alg 凝胶微球的制备及其对 As(V)的高效吸附
Int J Biol Macromol. 2019 Oct 15;139:886-895. doi: 10.1016/j.ijbiomac.2019.08.070. Epub 2019 Aug 8.
3
Enhanced removal of bisphenol A from aqueous solution by aluminum-based MOF/sodium alginate-chitosan composite beads.
基于铝基金属有机骨架/海藻酸钠-壳聚糖复合珠粒增强去除水溶液中的双酚 A。
Chemosphere. 2019 Dec;237:124493. doi: 10.1016/j.chemosphere.2019.124493. Epub 2019 Jul 30.
4
Vaccine Adjuvants Derived from Marine Organisms.海洋生物来源的疫苗佐剂。
Biomolecules. 2019 Aug 3;9(8):340. doi: 10.3390/biom9080340.
5
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting.基于壳聚糖纳米颗粒的药物递送与靶向的当前进展
Adv Pharm Bull. 2019 Jun;9(2):195-204. doi: 10.15171/apb.2019.023. Epub 2019 Jun 1.
6
Conversion of Chitin to Defined Chitosan Oligomers: Current Status and Future Prospects.将甲壳素转化为特定的壳寡糖:现状与未来展望。
Mar Drugs. 2019 Aug 1;17(8):452. doi: 10.3390/md17080452.
7
Two new tanshinone derivatives from the rhizomes of and their antiviral activities.从[植物名称]根茎中分离得到的两种新丹参酮衍生物及其抗病毒活性。 (你提供的原文中“from the rhizomes of ”后面缺少具体植物名称)
J Asian Nat Prod Res. 2020 Jan;22(1):24-29. doi: 10.1080/10286020.2019.1645132. Epub 2019 Aug 1.
8
The effect of oxidation degree and volume ratio of components on properties and applications of in situ cross-linking hydrogels based on chitosan and hyaluronic acid.氧化程度和组分体积比对基于壳聚糖和透明质酸的原位交联水凝胶性能和应用的影响。
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109670. doi: 10.1016/j.msec.2019.04.049. Epub 2019 Apr 25.
9
[Research progress on salvianolic acids of Salvia miltiorrhiza].[丹参中丹酚酸类成分的研究进展]
Zhongguo Zhong Yao Za Zhi. 2016 Mar;41(5):806-812. doi: 10.4268/cjcmm20160508.
10
Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases.丹参(Salvia miltiorrhiza Bunge):心血管疾病的潜在治疗圣药。
Curr Pharm Des. 2017;23(34):5125-5135. doi: 10.2174/1381612823666170822101112.